01228.HK
CANbridge Pharmaceuticals Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.01
+4.97%Margins
Gross margin
71.5%
EBITDA margin
-156.7%
EBIT margin
-177.7%
Net margin
-146.4%
FCF margin
-52.8%
41.6%
Return on equity
-42.4%
Return on assets
59.2%
Return on invested capital
0.29x
Asset turnover
-HKD 34.3M
Cash from operations
HKD 0.23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026